Arcus Biosciences, Inc. Capital Expenditures Incurred but Not yet Paid
Arcus Biosciences, Inc. (RCUS) reported Capital Expenditures Incurred but Not yet Paid of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-02-25
- Arcus Biosciences, Inc. capital expenditures incurred but not yet paid for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- Arcus Biosciences, Inc. capital expenditures incurred but not yet paid for the quarter ending 2024-12-31 was $0.00.
- Arcus Biosciences, Inc. capital expenditures incurred but not yet paid for the quarter ending 2024-09-30 was $0.00.
- Arcus Biosciences, Inc. capital expenditures incurred but not yet paid for the quarter ending 2024-06-30 was -$1.00M, a 125.00% decline year-over-year.
- Arcus Biosciences, Inc. capital expenditures incurred but not yet paid for fiscal 2025 was $0.00.
- Arcus Biosciences, Inc. capital expenditures incurred but not yet paid for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Arcus Biosciences, Inc. capital expenditures incurred but not yet paid for fiscal 2023 was $2.00M, a 33.33% decline from fiscal 2022.
- Arcus Biosciences, Inc. capital expenditures incurred but not yet paid for fiscal 2022 was $3.00M, a 200.00% increase from fiscal 2021.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 3 month as first filed | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 6 month as first filed | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 9 month as first filed | Capital Expenditures Incurred but Not yet Paid 12 month | Capital Expenditures Incurred but Not yet Paid 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-25 | |||||||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-06 | $0.00 derived: sum of 2 quarters · filed 2026-02-25 | $0.00 derived: sum of 3 quarters · filed 2026-02-25 | -$1.00M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $0.00 derived: sum of 2 quarters · filed 2026-02-25 | -$1.00M derived: sum of 3 quarters · filed 2026-02-25 | $0.00 10-K · filed 2026-02-25 | ||||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$1.00M derived: sum of 2 quarters · filed 2024-11-06 | $0.00 10-Q · filed 2024-11-06 | -$4.00M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-06-30 | -$1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | -$4.00M derived: sum of 3 quarters · filed 2026-02-25 | -$6.00M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-03-31 | $1.00M 10-Q · filed 2025-05-06 | -$3.00M derived: sum of 2 quarters · filed 2026-02-25 | -$5.00M derived: sum of 3 quarters · filed 2026-02-25 | -$1.00M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2023-12-31 | -$4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$6.00M derived: sum of 2 quarters · filed 2026-02-25 | -$2.00M derived: sum of 3 quarters · filed 2026-02-25 | $2.00M 10-K · filed 2026-02-25 | ||||
| 2023-09-30 | -$2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $2.00M derived: sum of 2 quarters · filed 2024-11-06 | $6.00M 10-Q · filed 2024-11-06 | $8.00M derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-06-30 | $4.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $8.00M 10-Q · filed 2024-08-08 | $10.00M derived: sum of 3 quarters · filed 2025-02-25 | $10.00M derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-03-31 | $4.00M 10-Q · filed 2024-05-08 | $6.00M derived: sum of 2 quarters · filed 2025-02-25 | $6.00M derived: sum of 3 quarters · filed 2025-02-25 | $6.00M derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2022-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $2.00M derived: sum of 2 quarters · filed 2025-02-25 | $2.00M derived: sum of 3 quarters · filed 2025-02-25 | $3.00M 10-K · filed 2025-02-25 | ||||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $0.00 derived: sum of 2 quarters · filed 2023-11-07 | $1.00M 10-Q · filed 2023-11-07 | $1.33M 10-Q · filed 2022-11-02 | -$2.60M derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $1.00M 10-Q · filed 2023-08-07 | $617.00K 10-Q · filed 2022-08-03 | -$2.60M derived: sum of 3 quarters · filed 2024-02-21 | -$4.49M derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2022-03-31 | $1.00M 10-Q · filed 2023-05-09 | $691.00K 10-Q · filed 2022-05-09 | -$2.60M derived: sum of 2 quarters · filed 2024-02-21 | -$4.49M derived: sum of 3 quarters · filed 2024-02-21 | -$784.00K derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2021-12-31 | -$3.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | -$5.49M derived: sum of 2 quarters · filed 2024-02-21 | -$1.78M derived: sum of 3 quarters · filed 2024-02-21 | $1.00M 10-K · filed 2024-02-21 | $996.00K 10-K · filed 2022-02-23 | |||
| 2021-09-30 | -$1.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $1.82M derived: sum of 2 quarters · filed 2022-11-02 | $4.61M 10-Q · filed 2022-11-02 | $6.36M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-06-30 | $3.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $6.49M 10-Q · filed 2022-08-03 | $8.24M derived: sum of 3 quarters · filed 2023-02-28 | $8.38M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-03-31 | $2.78M 10-Q · filed 2022-05-09 | $4.54M derived: sum of 2 quarters · filed 2023-02-28 | $4.67M derived: sum of 3 quarters · filed 2023-02-28 | $4.71M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | $1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $1.89M derived: sum of 2 quarters · filed 2023-02-28 | $1.92M derived: sum of 3 quarters · filed 2023-02-28 | $2.00M 10-K · filed 2023-02-28 | $1.58M 10-K · filed 2021-02-25 | |||
| 2020-09-30 | $135.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $169.00K derived: sum of 2 quarters · filed 2021-11-08 | $245.00K 10-Q · filed 2021-11-08 | $224.00K derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2020-06-30 | $34.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $110.00K 10-Q · filed 2021-08-05 | $89.00K derived: sum of 3 quarters · filed 2022-02-23 | $74.00K derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2020-03-31 | $76.00K 10-Q · filed 2021-05-05 | $55.00K derived: sum of 2 quarters · filed 2022-02-23 | $40.00K derived: sum of 3 quarters · filed 2022-02-23 | -$292.00K derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2019-12-31 | -$21.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | -$36.00K derived: sum of 2 quarters · filed 2022-02-23 | -$368.00K derived: sum of 3 quarters · filed 2022-02-23 | $12.00K 10-K · filed 2022-02-23 | ||||
| 2019-09-30 | -$15.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$347.00K derived: sum of 2 quarters · filed 2020-11-05 | $33.00K 10-Q · filed 2020-11-05 | $66.00K derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | -$332.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $48.00K 10-Q · filed 2020-08-06 | $81.00K derived: sum of 3 quarters · filed 2021-02-25 | -$823.00K derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | $380.00K 10-Q · filed 2020-05-05 | $413.00K derived: sum of 2 quarters · filed 2021-02-25 | -$491.00K derived: sum of 3 quarters · filed 2021-02-25 | -$179.00K derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | $33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$871.00K derived: sum of 2 quarters · filed 2021-02-25 | -$559.00K derived: sum of 3 quarters · filed 2021-02-25 | $136.00K 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | -$904.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$592.00K derived: sum of 2 quarters · filed 2019-11-05 | $103.00K 10-Q · filed 2019-11-05 | $418.00K derived: sum of 4 quarters · filed 2019-11-05 | ||||
| 2018-06-30 | $312.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $1.01M 10-Q · filed 2019-08-06 | $1.32M derived: sum of 3 quarters · filed 2019-08-06 | $850.00K derived: sum of 4 quarters · filed 2019-08-06 | ||||
| 2018-03-31 | $695.00K 10-Q · filed 2019-05-02 | $1.01M derived: sum of 2 quarters · filed 2019-05-02 | $538.00K derived: sum of 3 quarters · filed 2019-05-02 | -$67.00K derived: sum of 4 quarters · filed 2019-05-02 | ||||
| 2017-12-31 | $315.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-05 | -$157.00K derived: sum of 2 quarters · filed 2019-03-05 | -$762.00K derived: sum of 3 quarters · filed 2019-03-05 | $338.00K 10-K · filed 2019-03-05 | ||||
| 2017-09-30 | -$472.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$1.08M derived: sum of 2 quarters · filed 2018-11-08 | $23.00K 10-Q · filed 2018-11-08 | |||||
| 2017-06-30 | -$605.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | $495.00K 10-Q · filed 2018-08-06 | ||||||
| 2017-03-31 | $1.10M 10-Q · filed 2018-05-09 | |||||||
| 2016-12-31 | $618.00K 10-K · filed 2019-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| PRECIGEN, INC. (PGEN) | United States | $2.757B | -12.94 |
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |